Early experience with percutaneous LAA closure documented complication rates of ∼10%, with failure to implant devices in ∼10% of patients. These numbers are unrecognizable in contemporary practice due to the iterative changes made largely in the last 10 years. Here we look forward to ask what might change, and when, to bring percutaneous LAA closure out of the niche early adopter centers into routine use. We consider the opportunity to incorporate different technologies into LAAc devices in the context of managing patient with atrial fibrillation. Finally, we consider how to make the procedure safer and more effective.
Keywords: Atrial fibrillation; Device thrombus; Intracerebral hemorrhage; Invasive pressure monitor; Left atrial appendage; Oral anticoagulant.
Copyright © 2021 Elsevier Inc. All rights reserved.